Serum vascular endothelial growth factor receptor 2 and adropin levels in age related macular degeneration
Yazarlar (5)
Nurgül Örnek Kirikkale Üniversitesi, Türkiye
Prof. Dr. Kemal ÖRNEK Kirikkale Üniversitesi, Türkiye
Süleyman Aydın Firat Üniversitesi, Türkiye
Musa Yılmaz Firat Üniversitesi, Türkiye
Yaşar Ölmez Kirikkale Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | International Journal of Ophthalmology | ||
| Dergi ISSN | 2222-3959 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 04-2016 |
| Kabul Tarihi | 12-04-2026 | Yayınlanma Tarihi | – |
| Cilt / Sayı / Sayfa | 9 / 4 / 556–560 | DOI | 10.18240/ijo.2016.04.13 |
| Makale Linki | http://ies.ijo.cn/create_pdf.aspx?file_no=20160413&flag=1&journal_id=gjyken | ||
| Özet |
| AIM To investigate the serum levels of vascular endothelial growth factor receptor-2 (VEGFR-2) and adropin in age-related macular degeneration (AMD) patients. METHODS Ninety-eight AMD patients were included in the study. Seventy-eight age- and sex-matched healthy volunteers were recruited as the control group. Fundus florescein angiography and optical coherence tomography were performed to assess the posterior segment details. Serum VEGFR-2 and adropin levels were measured using enzyme-linked immunosorbent assays and compared between the study groups. RESULTS AMD group had significantly increased foveal retinal thickness, serum LDL and HDL levels and significantly decreased subfoveal choroidal thickness (P =0.01, 0.047, 0.025 and <0.001, respectively). Serum VEGFR-2 level revealed a significant decrease in AMD patients compared to controls (26.48±6.44 vs 30.42±7.92 ng/mL … |
| Anahtar Kelimeler |
| Adropin | Age-related macular degeneration | Vascular endothelial growth factor receptor-2 |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 11 |
| Scopus | 2 |
| Web of Science | 8 |